Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
The PI3K-Akt-CCND2 axis couples metabolic reprogramming with macrophage M1 polarization
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 13 May 2026

The PI3K-Akt-CCND2 axis couples metabolic reprogramming with macrophage M1 polarization

  • Xiaoyu Liu1,
  • Wei Shi1,
  • Lin Chai1,
  • Jianyuan Liu1,
  • Yanqian Su1,
  • Shuxing Wei1,
  • Chunkai Jia2,
  • Xiaomei Zhu3 &
  • …
  • Shubin Guo3 

Scientific Reports (2026) Cite this article

  • 366 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Cell biology
  • Diseases
  • Immunology
  • Molecular biology

Abstract

Dysregulated macrophage M1 polarization is a core pathological feature of inflammatory disorders. However, the crosstalk between metabolic reprogramming and cell-cycle regulator Ccnd2 during macrophage polarization remains largely unclear. This study explored the role of the PI3K-Akt-Ccnd2 axis in LPS-induced macrophage inflammation and verified its therapeutic potential in sepsis-associated acute kidney injury (SA-AKI). In vitro experiments were performed using RAW264.7 macrophages (Sham, LPS, PI3K inhibitor + LPS, M-CSF alone, M-CSF + LPS, Ccnd2 inhibitor, Ccnd2 inhibitor + Akt activator). In vivo studies were conducted using a cecal ligation and puncture (CLP)-induced SA-AKI mouse model with M-CSF intervention. Transcriptomic/metabolomic profiling, Western blotting, qRT-PCR, flow cytometry, and histopathological analysis were applied. Renal function, systemic inflammation, and signaling pathway activation were evaluated. LPS triggered transcriptional reprogramming enriched in PI3K-Akt, cell-cycle, and inflammatory pathways, and downregulated Ccnd2 expression; M-CSF restored Ccnd2 via PI3K-Akt signaling, which was abolished by PI3K inhibition. Metabolomic analysis identified marked alterations in purine, glycerophospholipid, and amino acid metabolism in LPS-stimulated macrophages. LPS enhanced M1 polarization, whereas M-CSF or PI3K inhibition suppressed this effect. In CLP mice, M-CSF significantly reduced serum Cre/BUN levels, alleviated systemic inflammation and renal histopathological damage, and activated the renal PI3K-Akt-Ccnd2 axis; these renoprotective effects were reversed by PI3K inhibition. LPS-induced metabolic reprogramming cooperates with PI3K-Akt signaling to regulate Ccnd2, thereby coupling macrophage cell-cycle progression and M1 polarization. The PI3K-Akt-Ccnd2 axis modulates macrophage inflammation in vitro and ameliorates CLP-induced SA-AKI in vivo, representing a promising therapeutic target for sepsis and related inflammatory organ injury. The PI3K-Akt-Ccnd2 axis may represent a candidate for further investigation for sepsis and other inflammatory disorders.

Similar content being viewed by others

CX3CL1 deficiency ameliorates acute kidney injury by inhibiting macrophage mitochondrial dysfunction and mtDNA-cGAS-STING signaling

Article Open access 13 December 2025

α7 nicotinic acetylcholine receptor agonist attenuates lipopolysaccharide-induced acute kidney injury in mice by reducing CCL2 expression in macrophages

Article Open access 14 November 2025

Comparison of sepsis-associated acute kidney injury with different degrees and causes reveals patterns in mitochondrial metabolism and immune infiltration changes

Article Open access 02 July 2025

Acknowledgements

The authors express their gratitude to the administrative support provided by Medical Research Center of Capital Medicial University.

Funding

This work was supported by the National Natural Science Foundation of China (No. 82172123).

Author information

Authors and Affiliations

  1. Emergency Medicine Clinical Research Center, Capital Medical University, Beijing, China

    Xiaoyu Liu, Wei Shi, Lin Chai, Jianyuan Liu, Yanqian Su & Shuxing Wei

  2. The First Hospital of Tsinghua University, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China

    Chunkai Jia

  3. Beijing Chaoyang Hospital Affiliated to Capital Medical University Emergency Medicine Clinical Research Center, Beijing, China

    Xiaomei Zhu & Shubin Guo

Authors
  1. Xiaoyu Liu
    View author publications

    Search author on:PubMed Google Scholar

  2. Wei Shi
    View author publications

    Search author on:PubMed Google Scholar

  3. Lin Chai
    View author publications

    Search author on:PubMed Google Scholar

  4. Jianyuan Liu
    View author publications

    Search author on:PubMed Google Scholar

  5. Yanqian Su
    View author publications

    Search author on:PubMed Google Scholar

  6. Shuxing Wei
    View author publications

    Search author on:PubMed Google Scholar

  7. Chunkai Jia
    View author publications

    Search author on:PubMed Google Scholar

  8. Xiaomei Zhu
    View author publications

    Search author on:PubMed Google Scholar

  9. Shubin Guo
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Xiaomei Zhu or Shubin Guo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (download PNG )

Supplementary Material 2 (download PNG )

Supplementary Material 3 (download PNG )

Supplementary Material 4 (download XLSX )

Supplementary Material 5 (download XLSX )

Supplementary Material 6 (download TIF )

Supplementary Material 7 (download TIF )

Supplementary Material 8 (download TIF )

Supplementary Material 9 (download TIF )

Supplementary Material 10 (download TIF )

Supplementary Material 11 (download TIF )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, X., Shi, W., Chai, L. et al. The PI3K-Akt-CCND2 axis couples metabolic reprogramming with macrophage M1 polarization. Sci Rep (2026). https://doi.org/10.1038/s41598-026-51817-z

Download citation

  • Received: 23 January 2026

  • Accepted: 30 April 2026

  • Published: 13 May 2026

  • DOI: https://doi.org/10.1038/s41598-026-51817-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Sepsis
  • Macrophage polarization
  • Ccnd2
  • Metabolic reprogramming
  • PI3K-Akt signaling
  • LPS
  • Inflammation
  • Transcriptomics
  • Metabolomics
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing